Alemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody.

PubWeight™: 1.62‹?› | Rank: Top 4%

🔗 View Article (PMC 2952475)

Published in Transplantation on April 27, 2008

Authors

Ron Shapiro1, Adriana Zeevi, Amit Basu, Henkie P Tan, Liise K Kayler, Deanna M Blisard, Ngoc L Thai, Alin L Girnita, Parmjeet S Randhawa, Edward A Gray, Amadeo Marcos, Thomas E Starzl

Author Affiliations

1: Department of Surgery, The Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA. shapiror@upmc.edu

Articles cited by this

Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant (2004) 4.04

Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant (2003) 2.83

Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H). Transplantation (2003) 2.48

Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48

Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients. Lancet (1998) 2.26

Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93

Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant (2003) 1.58

Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation. Transplantation (1998) 1.57

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study. Am J Transplant (2007) 1.43

Transplanting patients with a positive donor-specific crossmatch: a single center's perspective. Pediatr Transplant (2004) 1.38

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36

Flow cytometric detection of HLA antibodies using a spectrum of microbeads. Hum Immunol (1999) 1.34

HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant (2004) 1.27

The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant (2007) 1.19

A personal history of the CAMPATH-1H antibody. Med Oncol (2002) 1.12

Articles by these authors

Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med (2013) 6.31

Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection. J Heart Lung Transplant (2005) 5.87

Tolerogenic immunosuppression for organ transplantation. Lancet (2003) 4.09

Production of alpha 1,3-galactosyltransferase-deficient pigs. Science (2002) 3.96

Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant (2007) 3.90

Renal transplantation in elderly patients older than 70 years of age: results from the Scientific Registry of Transplant Recipients. Transplantation (2007) 3.69

A randomized trial of inhaled cyclosporine in lung-transplant recipients. N Engl J Med (2006) 3.16

Generation of cloned transgenic pigs rich in omega-3 fatty acids. Nat Biotechnol (2006) 3.07

Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55

One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation. Liver Transpl (2002) 2.38

The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study. PLoS Med (2014) 2.38

VENO-VENOUS BYPASS WITHOUT SYSTEMIC ANTICOAGULATION IN CANINE AND HUMAN LIVER TRANSPLANTATION. Surg Forum (1983) 2.30

Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells. Transfusion (2006) 2.26

Assessing relative risks of infection and rejection: a meta-analysis using an immune function assay. Transplantation (2006) 2.24

THE USE OF COMBINED PRESERVATION TECHNIQUES FOR EXTENDED STORAGE OF ORTHOTOPIC LIVER HOMOGRAFTS. Surg Gynecol Obstet (1968) 2.20

The impact of postreperfusion syndrome on short-term patient and liver allograft outcome in patients undergoing orthotopic liver transplantation. Liver Transpl (2008) 2.11

Cold pulsatile perfusion of pediatric kidney allografts. Transplantation (2008) 2.02

National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant (2004) 2.01

Kidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath. J Am Coll Surg (2005) 1.93

The hepatoadrenal syndrome: a common yet unrecognized clinical condition. Crit Care Med (2005) 1.75

Complications of right lobe living donor liver transplantation. J Hepatol (2009) 1.73

Successful treatment of small-for-size syndrome in adult-to-adult living-related liver transplantation: single center series. Clin Transplant (2007) 1.70

Polyomavirus allograft nephropathy: sequential assessment of histologic viral load, tubulitis, and graft function following changes in immunosuppression. Am J Transplant (2003) 1.64

Immunosuppression for liver transplantation in HCV-infected patients: mechanism-based principles. Liver Transpl (2005) 1.61

EFFECT OF CYCLOSPORIN ON HEPATIC REGENERATION. Surg Forum (1986) 1.59

Immune cell function testing: an adjunct to therapeutic drug monitoring in transplant patient management. Clin Transplant (2003) 1.58

Hypophosphatemia after 95 right-lobe living-donor hepatectomies for liver transplantation is not a significant source of morbidity. Transplantation (2003) 1.57

Glomerular changes in BK virus nephropathy. Hum Pathol (2004) 1.54

The association of community health indicators with outcomes for kidney transplant recipients in the United States. Arch Surg (2012) 1.53

Pediatric living donor kidney transplantation under alemtuzumab pretreatment and tacrolimus monotherapy: 4-year experience. Transplantation (2008) 1.52

Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning. Ann Surg (2003) 1.52

Acute antibody-mediated rejection of cardiac transplants. J Heart Lung Transplant (2006) 1.48

Functionally important glycosyltransferase gain and loss during catarrhine primate emergence. Proc Natl Acad Sci U S A (2006) 1.46

HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant (2005) 1.46

Cardiac tamponade in an orthotopic liver recipient with pulmonary hypertension. Crit Care Med (2002) 1.44

Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus. Transplantation (2004) 1.43

Transplantation of en bloc pediatric kidneys when the proximal vascular cuff is too short. Transplantation (2007) 1.42

Proposed live donor nephrectomy complication classification scheme. Transplantation (2006) 1.41

Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant (2011) 1.40

Duplicate gallbladder arising from the left hepatic duct: report of a case. Surg Today (2009) 1.39

SUCCESSFUL ORTHOTOPIC TRANSPLANTATION OF LIVER HOMOGRAFTS AFTER EIGHT TO TWENTY-FIVE HOURS PRESERVATION. Surg Forum (1967) 1.37

Antilymphoid antibody preconditioning and tacrolimus monotherapy for pediatric kidney transplantation. J Pediatr (2006) 1.36

MELD and prediction of post-liver transplantation survival. Liver Transpl (2006) 1.33

Adult living donor versus deceased donor liver transplantation: a 6-year single center experience. Am J Transplant (2005) 1.31

Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression. Ann Surg (2013) 1.30

Survival in allosensitized children after listing for cardiac transplantation. J Heart Lung Transplant (2007) 1.30

Statin use is associated with improved function and survival of lung allografts. Am J Respir Crit Care Med (2003) 1.28

Tacrolimus dosing in pediatric heart transplant patients is related to CYP3A5 and MDR1 gene polymorphisms. Am J Transplant (2003) 1.28

HLA-specific antibodies are associated with high-grade and persistent-recurrent lung allograft acute rejection. J Heart Lung Transplant (2004) 1.27

Disparate distribution of 16 candidate single nucleotide polymorphisms among racial and ethnic groups of pediatric heart transplant patients. Transplantation (2006) 1.24

Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology (2006) 1.24

Origin of lymph node-derived lymphocytes in human hepatic allografts. Clin Transpl (1989) 1.24

Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis (2006) 1.23

Porcine partial liver transplantation: a novel model of the "small-for-size" liver graft. Liver Transpl (2004) 1.22

Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg (2009) 1.21

Effect of liver transplantation on inflammatory bowel disease in patients with primary sclerosing cholangitis. Hepatology (2002) 1.21

Dendritic cell subset ratio in peripheral blood correlates with successful withdrawal of immunosuppression in liver transplant patients. Am J Transplant (2003) 1.21

Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation (2003) 1.18

Molecular basis of evolutionary loss of the alpha 1,3-galactosyltransferase gene in higher primates. J Biol Chem (2001) 1.18

Cytokine gene polymorphisms moderate illness severity in infants with respiratory syncytial virus infection. Hum Immunol (2003) 1.17

Immunogenicity and immunomodulatory effects of amnion-derived multipotent progenitor cells. Hum Immunol (2008) 1.16

Antibody-mediated rejection in kidney transplantation: a review. J Transplant (2012) 1.12

Anti-HLA antibody analysis and crossmatching in heart and lung transplantation. Transpl Immunol (2004) 1.12

Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol (2006) 1.12

OKT3 and viral disease in pediatric liver transplant recipients. Clin Transplant (1991) 1.11

Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J Gen Virol (2009) 1.11

Early outcomes in human lung transplantation with Thymoglobulin or Campath-1H for recipient pretreatment followed by posttransplant tacrolimus near-monotherapy. J Thorac Cardiovasc Surg (2005) 1.10

Proteasome inhibitor-based therapy for antibody-mediated rejection. Kidney Int (2012) 1.10

Dendritic cell subset ratio in tolerant, weaning and non-tolerant liver recipients is not affected by extent of immunosuppression. Am J Transplant (2005) 1.09

Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. J Hepatol (2008) 1.08

Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am J Obstet Gynecol (2003) 1.08

Single versus en bloc kidney transplantation from pediatric donors less than or equal to 15 kg. Transplantation (2008) 1.08